New drug put to the test: first human safety check begins
NCT ID NCT07474545
First seen Mar 16, 2026 · Last updated May 16, 2026 · Updated 8 times
Summary
This early-stage study tests a single injection of a new drug called KL0011034 in 76 healthy Chinese volunteers aged 18-45. The main goal is to check for side effects and measure how the drug moves through the body. Participants are randomly assigned to receive the drug, a placebo, or an active comparator. No direct health benefit is expected; the study gathers essential safety data before future trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Third XIANGYA Hospital of Central South University
Changsha, Hunan, 410205, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.